Erdogan, Turkey: Thanks to the leaders of Somalia and Ethiopia for achieving historical reconciliation.Morgan Stanley upgraded the rating of Jingao Technology to over-allocation, with a target price of RMB 27.36. Tongwei shares will be upgraded to overweight with a target price of RMB 39.53.NASDAQ China Golden Dragon Index closed down 0.74%, NASDAQ China Golden Dragon Index closed down 0.74%, most popular Chinese stocks fell, Tencent Music fell more than 5%, JD.COM fell more than 3%, Xpeng Motors fell more than 2%, and Bali, Weilai and Pinduoduo fell more than 1%. In terms of gains, Tiger Securities rose more than 3%, while Youdao and Gaotu rose more than 1%.
Imperial Commercial Bank of Canada: cut the preferential loan interest rate in Canada by 50 basis points to 5.45%.NASDAQ China Golden Dragon Index closed down 0.74%, NASDAQ China Golden Dragon Index closed down 0.74%, most popular Chinese stocks fell, Tencent Music fell more than 5%, JD.COM fell more than 3%, Xpeng Motors fell more than 2%, and Bali, Weilai and Pinduoduo fell more than 1%. In terms of gains, Tiger Securities rose more than 3%, while Youdao and Gaotu rose more than 1%.Coinbase: please note that some users may encounter higher transmission failure rate and delayed reception of BTC, LTC, ZCASH, BCH and DASH than usual.
Jingye Intelligent: Shareholders intend to transfer 1.5% of the company's shares by inquiry. Jingye Intelligent (688290) announced on the evening of December 12 that Hangshi Asset Management (Hangzhou) Co., Ltd., a shareholder holding 6.35% of the company, intends to transfer 1.53 million shares by inquiry, accounting for 1.5% of the company's total share capital. The transferee of this inquiry transfer is an institutional investor with corresponding pricing ability and risk tolerance.Peter Orsag, CEO of Lazard Financial Advisor, said that we should be encouraged by the key figures appointed by the president.Dongcheng Pharmaceutical's equity distribution plan for the first three quarters: 0.5 yuan will be paid a cash dividend for every 10 shares. Dongcheng Pharmaceutical (002675) announced on the evening of December 12 that the company's equity distribution plan for the first three quarters of 2024 is: based on the total share capital of 825 million shares on September 30, 2024, all shareholders will be paid a cash dividend of 0.5 yuan (including tax) for every 10 shares, totaling 41,229,800 yuan.
Strategy guide
12-14
Strategy guide
12-14